No |
Name |
Type |
Devt Phase /Application |
Slide Deck |
1 |
Biologics |
Preclinical Testing |
||
2 |
Biologics |
Preclinical Testing |
||
3 |
PD-L1/TIM-3/CSF-1R antibody in preclinical studies for Cancer Immunotherapy |
Biologics |
Lead Discovery /Optimization |
|
4 |
Biologics |
Lead Discovery /Optimization |
||
5 |
UB-941: A Selective & Orally Active Raf Kinase Inhibitor as a Precision Medicine /Melanoma |
Small Molecule |
IND Ready |
|
6 |
Small Molecule |
Preclinical Testing |
||
7 |
Small Molecule |
Lead Discovery /Optimization |
||
8 |
Platform |
Antibody, Protein, Peptide |
||
9 |
Platform |
Antibody, Protein, Peptide |
||
10 |
mRNA-LNP Development |
Platform |
Nucleic Acid Drug |
|
11 |
DCB-Asset List & Current Pipeline |
|
|